Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
J Chem Phys ; 146(14): 144306, 2017 Apr 14.
Article in English | MEDLINE | ID: mdl-28411616

ABSTRACT

Electron energy loss spectra of carbon tetrafluoride, silicon tetrafluoride, and germanium tetrafluoride molecules (CF4, SiF4, and GeF4) have been measured for incident electron energies of 50-360 eV at 1.5°-15.5° and for 30 eV and 30° scattering angle, while sweeping the energy loss over the range 9.0-20.0 eV. Low-lying valence excited triplet and singlet states are investigated by quantum chemical ab initio calculations. The Rydberg series converging to the (lowest) ionisation energy limits of XF4 (X = C, Si, Ge) are also identified and classified using the systematic behaviour according to the magnitude of the quantum defects. A generalized oscillator strength analysis is employed to derive oscillator strength f0 value and the apparent Born integral cross sections from the corresponding differential cross sections by using the Vriens formula for the optically allowed transitions. The f0 value is compared with the optical oscillator strength of the photoabsorption, pseudo-photon measurements, and theoretical values. The binary-encounter and f-scaled Born cross sections of the most intense optically allowed transitions have been also derived from the excitation threshold to the high energy region where the Born approximation is valid. Potential energy curves were obtained along the XF3 + F coordinate with two different basis sets to lend support on electron impact dissociation processes yielding radical formation. We found that in CF4, the lowest-lying dissociative character is due to intramolecular conversion from Rydberg 3s to valence character (σ*(C-F)), whereas in SiF4 and GeF4, an antibonding behaviour prevails.

2.
J Phys Chem A ; 120(46): 9170-9177, 2016 Nov 23.
Article in English | MEDLINE | ID: mdl-27783519

ABSTRACT

Electron energy loss (EEL) spectra of GeF4 have been measured with incident electrons at 100 eV for 5° scattering angle and at 30 eV for 30° scattering angle, while sweeping the energy loss over the range 7.0-18.0 eV. Low-lying excited triplet, singlet, valence, and Rydberg states are investigated and the assignments supported by quantum chemical ab initio calculations. This provides the first comprehensive investigation of all singlet and triplet excited electronic states of germanium tetrafluoride up to the first ionization energy. The Rydberg series converging to the (lowest) ionization energy limits of GeF4 are also identified according to the magnitude of the quantum defects (δ).

3.
Am J Cardiol ; 87(4): 387-91, 2001 Feb 15.
Article in English | MEDLINE | ID: mdl-11179519

ABSTRACT

The aim of this intravascular ultrasound study was to compare the type and the degree of vessel remodeling in proximal and distal de novo lesions within the same coronary artery in patients with stable angina pectoris. Seventy-six de novo coronary artery lesions in 38 coronary arteries of 38 patients were imaged by intravascular ultrasound. The vessel area (VA) within the external elastic lamina and the lumen area (LA) were measured, and the wall area (VA-LA) was calculated at the lesion site, and the proximal and distal reference sites. The VA ratio was defined as (lesion VA/average of the proximal and distal reference VAs) to represent the degree of vessel remodeling. The proximal coronary segments showed compensatory enlargement more often (68% vs 29%, p < 0.01) than the distal segments, and the VA ratio at the lesion site was significantly larger (1.1 +/- 0.3 vs 1.0 +/- 0.2, p <0 .01) in proximal segments than in distal segments. The type of coronary remodeling was discordant in 61% and concordant in only 39% of coronary arteries between the proximal and distal segments. The type of coronary remodeling of proximal and distal coronary lesions was inhomogeneous, even within the same vessel. Proximal coronary segments showed more prominent compensatory enlargement than distal segments, which have a similar degree of luminal narrowings.


Subject(s)
Angina Pectoris/diagnostic imaging , Coronary Artery Disease/diagnostic imaging , Ultrasonography, Interventional , Adult , Aged , Aged, 80 and over , Analysis of Variance , Angina Pectoris/pathology , Coronary Artery Disease/pathology , Coronary Vessels/diagnostic imaging , Coronary Vessels/pathology , Humans , Image Processing, Computer-Assisted , Male , Middle Aged , Regression Analysis
4.
Jpn Circ J ; 61(6): 525-30, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9225199

ABSTRACT

Head-up tilt testing is widely used in the diagnosis of syncope of unknown origin. In this report, head-up tilt testing elucidated the etiology of cardiac asystole of unexpected and sudden onset during orthopedic surgery under epidural anesthesia in a 30-year-old woman. Conventional diagnostic approaches were ineffective. Venous pooling in the lower legs as a result of vasodilation and subsequent vagotony due to epidural anesthesia, a condition mimicking orthostatic stress, is proposed as the mechanism of asystole. Follow-up examinations over 16 months revealed no further syncope and a good clinical course. Head-up tilt testing was useful in determining etiology in this case.


Subject(s)
Anesthesia, Epidural/adverse effects , Heart Arrest/etiology , Syncope/physiopathology , Tilt-Table Test/methods , Adult , Electrocardiography , Female , Heart Arrest/diagnosis , Heart Rate , Humans , Orthopedics
5.
Clin Cardiol ; 20(3): 233-8, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9068908

ABSTRACT

BACKGROUND: Prolonged asystole is sometimes an extreme manifestation of neurally mediated syncope. HYPOTHESIS: To investigate the mechanism of head-up tilt testing-induced prolonged (life-threatening) cardiac asystole, we measured temporal changes in frequency domain heart rate variability indices in 25 patients with syncope of undetermined etiology. METHODS: Head-up tilt testing (80 degrees) was performed in 25 patients for up to 40 min or until asystole or syncope occurred. Three patients (Group 1; 37 +/- 13 years, 1 man 2 women) had an episode of prolonged cardiac asystole (> or = 10 s) during testing, necessitating cardiopulmonary resuscitation. Syncope, but no asystole, was induced in 10 patients (Group 2; 48 +/- 31 years, 6 men, 4 women), and 12 patients (Group 3; 55 +/- 20 years, 5 men, 7 women) failed to show asystole or syncope during testing. Power spectra of low (0.04-0.15 Hz) and high (0.15-0.40 Hz) frequency, and total (0.01-1.00 Hz) frequency spectra were measured in consecutive 2 min segments throughout the test. RESULTS: Maximally changed values in heart rate, systolic blood pressure, and heart rate variability indices during testing were compared among the three groups (maximally changed values did not include the values during tilt-induced symptoms). High frequency spectra in Groups 2 and 3, but not in Group 1, decreased during the test. High frequency spectra, low frequency spectra, and total spectra in Group 1 were significantly higher than those in Groups 2 and 3 during testing. In Group 1 patients, findings at test-induced asystole were consistent with exaggerated sympathetic and concurrent persistent parasympathetic activity. CONCLUSION: Unusual autonomic responses to orthostatic stress can cause prolonged asystole, and this autonomic nerve dysregulation may relate to asystolic episodes associated with cardiovascular collapse.


Subject(s)
Autonomic Nervous System/physiopathology , Heart Arrest/physiopathology , Tilt-Table Test , Adult , Blood Pressure , Cardiopulmonary Resuscitation , Female , Heart Arrest/etiology , Heart Rate , Humans , Male , Middle Aged , Syncope/etiology , Syncope/physiopathology , Vagus Nerve/physiopathology
7.
Clin Ther ; 17(6): 1126-35, 1995.
Article in English | MEDLINE | ID: mdl-8750404

ABSTRACT

The effects of long-term monotherapy with cilazapril, an angiotensin-converting enzyme inhibitor, on blood pressure, glucose tolerance, and serum lipid profiles were prospectively investigated in 66 patients with hypertension: 23 with normal glucose tolerance and 43 with glucose intolerance (including 9 patients with non-insulin-dependent diabetes mellitus). The levels of plasma glucose, serum insulin, serum lipids, glycated hemoglobin A(lc) (Hb A(lc)), and fructosamine were determined before and during long-term (mean +/- SD, 26.2 +/- 1.2 weeks) therapy with cilazapril. A 75-g oral glucose tolerance test was performed before and during treatment. Significant reductions in both systolic and diastolic blood pressures in both patient groups were maintained during the study. Neither fasting nor post-glucose load venous plasma glucose levels were altered in either group of patients, and no patient with normal glucose tolerance developed diabetes mellitus during the study. There was no significant change in the insulinogenic index (delta serum insulin/delta venous plasma glucose at 30 minutes post-glucose load) in either group, and glucose intolerance was slightly improved with significant reductions (P < 0.01) in Hb A(lc) and fructosamine in the patient group with impaired glucose tolerance. Serum total cholesterol (TC), low-density lipoprotein cholesterol, and triglyceride levels were significantly (P < 0.01) decreased and high-density lipoprotein cholesterol levels increased in patients with hypercholesterolemia (TC levels > or = 5.69 mmol/L). These results suggest that long-term cilazapril therapy may improve glucose and lipid metabolism in hypertensive patients with impaired glucose tolerance. Cilazapril also appears to be useful as an antihypertensive agent for hypertensive patients with either impaired glucose tolerance or hypercholesterolemia.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/pharmacology , Blood Glucose/metabolism , Cilazapril/pharmacology , Hypertension/blood , Lipids/blood , Angiotensin-Converting Enzyme Inhibitors/blood , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Blood Pressure/drug effects , Cilazapril/blood , Cilazapril/therapeutic use , Female , Glucose Intolerance/drug therapy , Glucose Tolerance Test , Humans , Hypercholesterolemia/drug therapy , Hypertension/drug therapy , Male , Prospective Studies
8.
Kokyu To Junkan ; 39(7): 709-13, 1991 Jul.
Article in Japanese | MEDLINE | ID: mdl-1910203

ABSTRACT

The patient was a 47 year-old man, who has been known to have effort angina since September 1989. His exercise stress ECG has revealed ST elevation in V2-V4 with maximum exercise. He experienced severe chest pain lasting for an hour on the way to his office in the early morning on November 16, 1989, and was admitted to our hospital. His ECG and laboratory findings indicated typical acute anteroseptal myocardial infarction, but the coronary arteriography (CAG) which was performed 7 hours after the onset showed no significant stenotic lesion. After administrating nitrate and calcium antagonist, he has had no attack of angina pectoris and his exercise stress test has revealed no ST-T changes on his ECG. 1 month later, while antianginal drugs were discontinued in order to perform an ergonovine stress test, the patient frequently complained of left anterior chest pain with remarkable ST elevation in precordial leads on his ECG. The CAG at chronic stage revealed that there was a 99% stenosis at Segment 6 of the left anterior descending artery (LAD) which was supplied with good collateral flow from the right coronary artery. The LAD was completely occluded at Segment 6 after intracoronary administration of ergonovine maleate 0.005 mg to the left coronary artery. After the intracoronary infusion of isosorbide dinitrate, there was no significant stenosis seen in the LAD except the minimum wall irregularity at Segment 6. These findings suggested that coronary spasm might play a major role of the occurrence of acute myocardial infarction in this case.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Coronary Vasospasm/complications , Myocardial Infarction/etiology , Calcium Channel Blockers/therapeutic use , Coronary Angiography , Creatine Kinase/blood , Ergonovine , Humans , Male , Middle Aged , Myocardial Infarction/drug therapy , Nitroglycerin/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...